Site is Being Upgraded

Lifespan- and healthspan-extension therapy: Snai1/Snail, a protein that promotes epithelial to mesenchymal transition, may increase life span via up-regulation of its target gene BubR1 and others, 3/June/2018, 11.00 pm

Unknown action of a known drug in rescuing blood sugar disease: Bromocriptine-based adjunct therapy for autoimmune diabetes (TIDM): Bromocriptine (trade name:Parlodel), used in the treatment of  pituitary tumors, Parkinson’s disease (PD), hyperprolactinaemia, infertility and others, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 3/June/2018, 7.32 pm
June 3, 2018
Interleukin-based therapy for body weight control, energy homeostasis and TIIDM: Interleukin-15 (IL-15) decreases CADM1 and its downstream target genes that inhibit glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 3/June/2017, 11.08 pm
June 3, 2018
Show all

 What they say: Introduction: 

A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School of Medicine, The University of New South Wales, Australia shows that Sirtuin-2 induces the checkpoint kinase BubR1 to increase lifespan. This study was published, in the 1 July  2014 issue of the journal  “EMBO”, by Prof Sinclair, North BJ, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Lifespan- and healthspan-extension therapy: Snai1/Snail, a protein that promotes epithelial to mesenchymal transition, may increase life span via up-regulation of its target gene BubR1 and others


From research findings to Therapeutic Opportunity: 

This study suggests, for the first time, that Snai1/Snailby increasing the expression of its target gene, it may: (a) increase the expression of BuBR1; (b) decrease the expression of p70 S6 Kinase; and (c) regulate the expression of a number of longevity-promoting molecules (fig. 1).

[easy_payment currency=”USD”]

Figure 1. Snai1/Snail may extend  mammalian life span via up regulation of BuBR1 and down regulation of p70 S6 Kinase

Figure 2. Snai1/Snail as a longevity-promoting agent.   It  functions as a longevity-promoter by increasing the expression of BuBR1 and other longevity-promoting genes (fig 1).

 

 

 

 

 

 

 

 

Thereby, it may: (1) increase insulin sensitivity; (2) attenuate cognitive impairment; (3) delay diseases of aging; (4) slow down cardiac aging; (5) promote resistance to bone, immune and motor dysfunction; (6) promote tissue rejuvenation; and (7) prolong median life span. Thus,a pharmaceutical mixture encompassing Snail activators, either alone or in combination with other drugs, may be used to extend the lifespan of an individual (fig.2).


Details on the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Amount: $500#

Undisclosed mechanistic information: How Snai1/Snail increases the expression of BubR1 and extends mammalian life-span

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

# Research cooperation


References

Web: http://genomediscovery.org or http://newbioideas.com

CitationBoominathan, L., Lifespan- and healthspan-extension therapy: Snai1/Snail, a protein that promotes epithelial to mesenchymal transition, may increase life span via up-regulation of its target gene BubR1 and others, 3/June/2018, 11.00 pm,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at admin@genomediscovery.org

Comments are closed.